Table 1.
Biomarker type | Definition | Example |
---|---|---|
Susceptibility/risk | Potential for developing a disease or medical condition | APOE for Alzheimer disease |
Diagnostic | Detect or confirm disease/condition | Rheumatoid factor for autoimmune disease |
Monitoring | Measured repeatedly for assessing state of the disease | Prostate-specific antigen (PSA), prostate cancer |
Predictive | Likelihood of experiencing a favorable or unfavorable response to treatment | BRCA1/2 for response to ADP-ribose-PARP inhibitors |
Response | Show a biological response has occurred when exposed to a treatment | C-reactive protein (CRP) for effective inflammatory disease treatment |
Safety | Prescence of toxicity as an adverse event | Creatinine for muscle damage |
APOE, apolipoprotein E; BRCA, BReast CAncer Gene; ADP, adenosine diphosphate; PARP, Poly-ADP ribose polymerase.